Healthpeak Properties, Inc. (NYSE:DOC) Receives Average Recommendation of "Hold" from Brokerages

Key Points

• Healthpeak Properties has an average analyst rating of "Hold", with 10 analysts recommending hold and 5 recommending buy. The consensus 1-year price target is about $19.23.
• The company recently beat first-quarter earnings expectations, reporting $0.45 EPS versus the $0.43 estimate, and revenue of $752.95 million, up 7.1% year over year.
• Healthpeak also announced a monthly dividend of $0.1017 per share, implying an annualized yield of about 6.1%, though its payout ratio is very high at 381.25%.

Healthpeak Properties, Inc. (NYSE:DOC - Get Free Report) has received an average recommendation of "Hold" from the fifteen analysts that are covering the firm, MarketBeat.com reports. Ten equities research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. The average 1-year target price among analysts that have issued ratings on the stock in the last year is $19.2308.

Several analysts have issued reports on DOC shares. Wells Fargo & Company reissued a "positive" rating on shares of Healthpeak Properties in a report on Tuesday, February 3rd. Scotiabank boosted their price target on Healthpeak Properties from $19.00 to $21.00 and gave the company a "sector perform" rating in a report on Wednesday. Weiss Ratings raised Healthpeak Properties from a "hold (c-)" rating to a "hold (c)" rating in a report on Friday, May 8th. Argus lowered Healthpeak Properties from a "buy" rating to a "hold" rating in a report on Thursday, February 5th. Finally, Wall Street Zen raised Healthpeak Properties from a "sell" rating to a "hold" rating in a research note on Sunday, May 10th.

Healthpeak Properties Stock Performance

NYSE:DOC opened at $19.85 on Thursday. The stock has a 50-day simple moving average of $17.66 and a two-hundred day simple moving average of $17.30. Healthpeak Properties has a 52-week low of $15.70 and a 52-week high of $20.27. The company has a debt-to-equity ratio of 1.15, a quick ratio of 2.96 and a current ratio of 2.96. The firm has a market capitalization of $13.69 billion, a PE ratio of 62.04, a P/E/G ratio of 2.54 and a beta of 1.00.

Healthpeak Properties (NYSE:DOC - Get Free Report) last released its quarterly earnings results on Tuesday, May 5th. The real estate investment trust reported $0.45 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.43 by $0.02. Healthpeak Properties had a return on equity of 2.61% and a net margin of 7.73%.The business had revenue of $752.95 million during the quarter, compared to analyst estimates of $694.59 million. During the same quarter in the previous year, the company posted $0.46 earnings per share. Healthpeak Properties's revenue for the quarter was up 7.1% on a year-over-year basis. Healthpeak Properties has set its FY 2026 guidance at 1.710-1.750 EPS. Analysts forecast that Healthpeak Properties will post 1.75 EPS for the current year.

Healthpeak Properties Announces Dividend

The firm also recently disclosed a monthly dividend, which will be paid on Friday, June 26th. Stockholders of record on Monday, June 15th will be paid a $0.1017 dividend. The ex-dividend date of this dividend is Monday, June 15th. This represents a c) dividend on an annualized basis and a dividend yield of 6.1%. Healthpeak Properties's dividend payout ratio is 381.25%.

Insider Buying and Selling at Healthpeak Properties

In other news, insider Scott R. Bohn sold 10,989 shares of the company's stock in a transaction dated Tuesday, May 12th. The stock was sold at an average price of $19.45, for a total value of $213,736.05. Following the completion of the transaction, the insider owned 7,636 shares of the company's stock, valued at $148,520.20. This represents a 59.00% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. 0.23% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On Healthpeak Properties

A number of hedge funds have recently made changes to their positions in the business. State Street Corp boosted its stake in shares of Healthpeak Properties by 1.8% in the third quarter. State Street Corp now owns 49,498,109 shares of the real estate investment trust's stock worth $947,889,000 after acquiring an additional 895,460 shares during the period. JPMorgan Chase & Co. boosted its stake in shares of Healthpeak Properties by 8.6% in the fourth quarter. JPMorgan Chase & Co. now owns 30,674,812 shares of the real estate investment trust's stock worth $493,251,000 after acquiring an additional 2,438,278 shares during the period. Fuller & Thaler Asset Management Inc. boosted its stake in shares of Healthpeak Properties by 19.2% in the fourth quarter. Fuller & Thaler Asset Management Inc. now owns 29,648,260 shares of the real estate investment trust's stock worth $476,744,000 after acquiring an additional 4,776,056 shares during the period. Geode Capital Management LLC boosted its stake in shares of Healthpeak Properties by 0.6% in the fourth quarter. Geode Capital Management LLC now owns 19,534,041 shares of the real estate investment trust's stock worth $312,959,000 after acquiring an additional 123,274 shares during the period. Finally, Invesco Ltd. boosted its stake in shares of Healthpeak Properties by 9.9% in the fourth quarter. Invesco Ltd. now owns 18,298,776 shares of the real estate investment trust's stock worth $294,244,000 after acquiring an additional 1,648,012 shares during the period. Institutional investors own 93.57% of the company's stock.

Healthpeak Properties Company Profile

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.